Infection prevention and control in health-care facilities in which hematopoietic cell transplant recipients are treated
Bone Marrow Transplant
.
2009 Oct;44(8):495-507.
doi: 10.1038/bmt.2009.261.
Authors
D Yokoe
1
,
C Casper
,
E Dubberke
,
G Lee
,
P Muñoz
,
T Palmore
,
K Sepkowitz
,
J-A H Young
,
J P Donnelly
;
Center for International Blood and Marrow Transplant Research
;
National Marrow Donor Program
;
European Blood and Marrow Transplant Group
;
American Society of Blood and Marrow Transplantation
;
Canadian Blood and Marrow Transplant Group
;
Infectious Disease Society of America
;
Society for Healthcare Epidemiology of America
;
Association of Medical Microbiology and Infectious Diseases Canada
;
Centers for Disease Control and Prevention
Affiliation
1
Brigham & Women's Hospital and Dana-Farber Cancer Institute, Boston, MA 02115, USA.
[email protected]
PMID:
19861984
DOI:
10.1038/bmt.2009.261
No abstract available
Publication types
Practice Guideline
MeSH terms
Contraindications
Hematopoietic Stem Cell Transplantation*
Humans
Immunocompromised Host*
Infection Control / methods*
Opportunistic Infections / immunology
Opportunistic Infections / prevention & control*
Vaccines
Substances
Vaccines